Although current therapies including, laser photocoagulation, anti-vascular endothelial growth factor (VEGF), and corticosteroid demonstrated significant efficacy in treating DR and prevention of its progression, they are still limited by their significant side effects incomplete ability to eliminate the risk of blindness, and mostly applied in late stages of the disease (8–10). This evidence concerns the gene VEGFA and blindness (disorder).